Patients with diabetes mellitus (DM) develop complications including coronary artery disease (CAD), which is the leading cause of mortality in this group of patients. One of the diagnostic modalities for early detection of myocardial ischemia in symptomatic and asymptomatic patients with DM is myocardial perfusion tomography (MPI).
I N T R O D U C T I O N
Patients with diabetes mellitus over time develop several long-term complications which reduce the quality of life and life expectancy. Coronary artery disease (CAD) is one of the complications with outmost significance. Frequently, CAD is diagnosed several years after the occurrence of complications. On the other side, CAD is the leading cause of morbidity and mortality in patients with DM (1). To be worse, CAD is often in advanced stage when the manifestations begin in patients with DM (2). In the management of these patients, it is important to find which patients can benefit from coronary angioplasty (CAG) and from percutaneous coronary angioplasty (PTCA) if it is needed, whether they are symptomatic or asymptomatic. Patients with DM and earlydiagnosed CAD can benefit from early intervention in the manner of increasing of long-term survival (3) . Myocardial perfusion imaging (MPI) using single photon emission tomography (SPECT) is reported to be useful in detection of myocardial ischemia in symptomatic and asymptomatic patients with diabetes mellitus (4) . Several different reports suggest 37% to 62% abnormal MPI findings in patients with DM (5). Perfusion defects found on MPI usually strongly suggests the existence of myocardial ischemia, or myocardial scar, and correlate with findings of coronary artery stenosis on CAG (6) .
A I M
The aim of this study was to correlate perfusion defects found on MPI with coronary artery stenosis found on CAG in patients who are in early stages of DM.
P A T I E N T S A N D M E T H O D O L O G Y
The total of 34 patients was examined, from January 2011 to December 2011, aged from 24 to 65 years. Nine of them were women and 15 were men. All of the patients were in early stages of type II DM (from six months to three years from the onset of DM). Average level of glucose in the blood in this group of patients was 11,1±3,3 mmol/L. There were 13 patients with symptomatology that can be related to coronary artery disease. All of them suffered from chest pain or discomfort, shortness of breath when exercising or during another vigorous activity, weakness, dizziness, nausea or increased sweating. Regarding CAD, twenty-one patients were symptom-free. All the patients had normal ECG.
MPI studies were done by standard two-day protocol (16) . On the first day, radiopharmaceutical was intravenously injected immediately after the treadmill ergo stress testing, and on the second day we performed the rest of the study. Treadmill ergo stress testing was done following the Bruce protocol, with the aim of achieving 85% of the maximal predicted heart rate, or it was symptom-limited (7) . Radiopharmaceutical was injected intravenously at the peak stress activity of the patient. In all studies, the radiopharmaceutical used was tetrakis (2-metoksiizobutil izonitril) copper 1 tetrafluoroborat, (STAMICIS, Iba Molecular, France) (8) . SPECT MPI images were acquired with double headedd gama camera equipped with high resolution colimators (E-cam, Siemens, Medica Solutions). Detectors of gamma camera were reconfigurated in 90 degrees position. Acquisitions were done by 64 projection angles, over a 180 degrees orbit, at 25 seconds duration of each projection. The image data from every projection were recorded in 16 equal time frames gated by ECG. Reconstruction of tomograms from acquired data were done by iterative reconstruction, with 12 iterations and Butterworth prefiltering with cuttof, 0,4 cycle/pixel. Through the reconstruction, for interpretation the available tomograms through long vertical, long horisontal and through short axis of the left heart ventricle myocardium were used. Qualitative analysis of tomograms was performed by nuclear medicine physician, and the findings were categorised as normal perfusion of the left ventricle, reversible perfusion defects, which indicated ischemia, and fixed perfusion defects that indicated myocardial scar (9) .
All patients with myocardial perfusion defects were elected for CAG. This method was done by the right femoral artery aproach, on Axiom Artis, Siemens, Germany devices. Interpretation of CAG findings was done by cardiologist, with categorisation of stenosis by its localisation and severity. Stenoses were categorised as significant in the manner of existing CAD, if narowing of the coronary artery lumen were 50% or greater (10) .
Findings from MPI and CAG were correlated with non-parametric statistical analysis.
R E S U L T S
Fifteen (44,12%) of 34 patients had normal left ventricle perfusion (Figure 1 ). In 19 (55,88%) patients, there were perfusion defects. Fixed defects were found in one patient and reversible defects were found in 18 patients. One patient with fixed perfusion defect was categorized as one who had non-ST elevation myocardial infarction (Figure 2) . The other 18 patients with reversible perfusion defects were categorized as patients with silent or apparent ischemia, according to whether they were with or without the CAD-related symptomatology ( Figure 3 ). On CAG, there were 12 (63,16%) patients with normal coronary arteries (Figure 4 ), 7 (36,84%) with significant coronary artery stenosis ( Figure 5 ). Statistical correlation between the group with perfusion defects on MPI and group with significant stenosis on CAG was done by non-parametric, Related-Samples Wilcoxon Signed Rank Test (Figure 6 ). The test shows that there was statistically lower detection of ischemia (stenosis) on CAG than on MPI findings (significance 0,01 at significance level 0,05) ( Figure 7) . 
Figure 1. Normal perfusion of the left heart ventricle on myocardial perfusion tomography. M.E. asymptomatic, 45 years old, female

Figure 2. Fixed perfusion defect of the anterior wall of the left ventricle (marked with arrows), detecting myocardial scar (Myocardial infarction). N.N. symptomatic, 40 years old, male
Figure 3. Reversible perfusion defect of the anteroseptal region and inferior wall (marked with arrows), detecting myocardial ischemia. T.O. asymptomatic, 52 years old, female
D I S C U S S I O N
This discrepancy between MPI ischemia positive findings and CAG normal coronary artery presentation can be explained by the fact that in early stages of DM, and especially in asymptomatic patients, there are no extensive atherosclerotic changes in arterial vessels, including coronary arteries (11) . Further, in the group of symptomatic patients, even with presentation of several risk factors for CAD, if they are able to successfully exercise, it must exclude high suspicion of CAB. In relatively "healthy" patients with DM, who are able to exercise, there is no likelihood of severe complications as peripheral artery disease and diabetic neuropathy. There is evidence of low coronary artery calcium (CAC) score in DM patients who are able to exercise, and further only patients with high CAC develop severe coronary events (12, 13) . This is another explanation of discrepancy between ischemia found on MPI and normal CAG presentation of epicardial coronary arteries.
Patients with MPI ischemia findings but without severe complication such as peripheral artery disease and polyneuropathy can benefit more from modification of pharmacologic therapy, than from eventual revascularization (14) . Vascular disease in early stages is not treatable with invasive therapy. Reducing ischemia in these cases can be achieved with intensification of therapy with statins, aspirin, and ACE inhibitors (15) . Fur-thermore, more careful follow-up of these patients can result in recognition of asymptomatic ischemia and then refer the patient to further analysis (16) . The combination of different diagnostic modalities and protocols can be the solution for election of the DM patients for CAG (17) .
C O N C L U S I O N
There is discrepancy between MPI findings of ischemia and CAG presentation of epicardial coronary arteries. This discrepancy is related to the existence of endothelial dysfunction rather than atherosclerosis. Patients with perfusion defects on MPI can benefit more from balanced pharmacological and invasive therapy than from revascularization only. MPI evaluation and CAG should be reserved for selected individuals with strong suspicion of high risk CAD.
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